IDEXX Laboratories Launches IDEXX EquiView® Direct Digital Laptop Radiography System for Equine [Trade]

The new laptop configuration offers instant viewing of images in their final format without the need for an entire study to be complete, and supplies the user with extraordinary image sharpness in just seconds—supporting a faster, more accurate diagnosis. Images can be easily adjusted, annotated, stored, printed and transferred via IDEXX-PACS™, the DICOM¹-conformant open-communication software system built into all IDEXX Digital Radiography Systems.

"The introduction of a laptop option for the IDEXX EquiView portable direct digital radiography system further demonstrates IDEXX's commitment to meeting the needs of our customers," said Paul Dobbins, General Manager, IDEXX Digital Imaging. "Our goal is to consistently improve our customer's ability to deliver high quality service."

The system includes an innovative wireless trigger that reduces the number of cables, an important safety concern when working with horses.

IDEXX pioneered digital radiography in equine veterinary medicine with the launch of the first portable equine veterinary-specific digital system in 2001. Equine veterinarians in all 50 United States and 10 countries are realizing the benefits from the commitment IDEXX has made to providing outstanding digital radiology technology, services and support.

For more information on the IDEXX EquiView Digital Radiography System, visit www.idexx.com/equiview. To schedule a field demonstration, please call 1-877-433-9922.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice-management systems, and therapeutics. Our products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Westbrook, Maine, IDEXX Laboratories employs more than 3,500 people and offers products to customers in over 100 countries.

Note Regarding Forward-Looking Statements

This press release contains statements about the Company's business prospects that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's expectations of future events as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Actual results could differ materially from management's expectations. Factors that could cause or contribute to such differences include the following: the Company's ability to develop, manufacture, introduce and market new products and enhancements to existing products; the effectiveness of the Company's sales and marketing activities; the Company's ability to develop, license or obtain rights to new technologies; the Company's ability to identify acquisition opportunities, complete acquisitions and integrate acquired businesses; the impact of competition and technological change on the markets for the Company's products; the effect of government regulation on the Company's business, including government decisions about whether and when to approve the Company's products and decisions regarding labeling, manufacturing and marketing products; the impact of distributor purchasing decisions on sales of our products that are sold through distribution; changes or trends in veterinary medicine that affect the rate of use of the Company's products and services by veterinarians; the Company's ability to obtain patent and other intellectual property protection for its products, successfully enforce its intellectual property rights and defend itself against third party claims against the Company; disruptions, shortages or pricing changes that affect the Company's purchases of products and materials from third parties, including from sole source suppliers; the effects of government regulatory decisions, customer demand, pricing and other factors on the realizability of the Company's inventories; the Company's ability to manufacture complex biologic products; the effects of operations outside the U.S., including from currency fluctuations, different regulatory, political and economic conditions, and different market conditions; and the loss of key employees. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2005 (PDF, 1.5 MB), and on the Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 (PDF, 520 KB), in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations."